BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,081 filers reported holding BAXTER INTL INC in Q1 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $60,009,000 | +28.8% | 738,029 | +4.3% | 0.07% | +10.6% |
| Q4 2018 | $46,594,000 | -77.5% | 707,906 | -73.7% | 0.07% | -47.2% |
| Q3 2018 | $207,404,000 | +105.3% | 2,690,414 | +96.7% | 0.12% | -0.8% |
| Q2 2018 | $101,006,000 | +4.0% | 1,367,897 | -8.4% | 0.13% | 0.0% |
| Q1 2018 | $97,164,000 | -1.6% | 1,493,908 | -2.2% | 0.13% | -0.8% |
| Q4 2017 | $98,720,000 | +1.9% | 1,527,226 | -1.1% | 0.13% | -3.1% |
| Q3 2017 | $96,902,000 | +3.8% | 1,544,253 | +0.1% | 0.13% | 0.0% |
| Q2 2017 | $93,370,000 | +29.3% | 1,542,288 | +10.8% | 0.13% | +24.8% |
| Q1 2017 | $72,213,000 | +20.6% | 1,392,456 | +3.1% | 0.10% | +11.7% |
| Q4 2016 | $59,871,000 | +3.4% | 1,350,276 | +11.0% | 0.09% | -2.1% |
| Q3 2016 | $57,903,000 | -1.6% | 1,216,446 | -6.5% | 0.10% | -6.8% |
| Q2 2016 | $58,820,000 | +17.7% | 1,300,742 | +6.9% | 0.10% | +13.2% |
| Q1 2016 | $49,990,000 | +106.7% | 1,216,906 | +92.0% | 0.09% | +102.2% |
| Q4 2015 | $24,179,000 | +17.1% | 633,797 | +0.8% | 0.04% | +9.8% |
| Q3 2015 | $20,655,000 | -54.7% | 628,771 | -3.6% | 0.04% | -51.8% |
| Q2 2015 | $45,599,000 | +13.2% | 652,064 | +10.9% | 0.08% | +13.3% |
| Q1 2015 | $40,272,000 | +25.8% | 587,907 | +34.6% | 0.08% | +23.0% |
| Q4 2014 | $32,002,000 | +5.7% | 436,650 | +3.5% | 0.06% | 0.0% |
| Q3 2014 | $30,288,000 | +1.0% | 422,012 | +1.8% | 0.06% | 0.0% |
| Q2 2014 | $29,978,000 | +1.3% | 414,640 | +3.1% | 0.06% | -4.7% |
| Q1 2014 | $29,599,000 | +7.2% | 402,271 | +1.3% | 0.06% | +3.2% |
| Q4 2013 | $27,606,000 | – | 396,924 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |